Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat Non-Hodgkin's Lymphoma (NHL)

Clinical trial NCT01685008 · COMPLETED

Trial details

NCT number: NCT01685008
Sponsor: MorphoSys AG
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma

Start date: 2013-04-23
Primary completion: 2022-04-06
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.